Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Fortrea Holdings Inc. - Common Stock
(NQ:
FTRE
)
22.78
+0.30 (+1.33%)
Streaming Delayed Price
Updated: 1:11 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Fortrea Holdings Inc. - Common Stock
< Previous
1
2
Next >
Fortrea Reports Second Quarter 2024 Results
August 12, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
July 17, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Appoints Robert Parks as Chief Accounting Officer
July 11, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
June 27, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
June 19, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
June 04, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Present at the Jefferies Global Healthcare Conference
June 03, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
May 30, 2024
Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trials
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Appoints Machelle Sanders to Board of Directors
May 16, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Reports First Quarter 2024 Results
May 13, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
May 06, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
April 11, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
March 11, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
March 11, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
February 20, 2024
Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
February 20, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
January 29, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
January 09, 2024
Companies partner to provide patients and sites with easy access to study information in one integrated solution
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Previews J.P. Morgan Healthcare Conference Updates
January 08, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Convenes New Site Advisory Board
December 13, 2023
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
November 20, 2023
Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Reports Third Quarter 2023 Results
November 13, 2023
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
November 02, 2023
Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers
From
Fortrea Holdings Inc
Via
GlobeNewswire
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit
October 17, 2023
From
Starboard Value LP
Via
Business Wire
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
October 13, 2023
Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call
October 11, 2023
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics
October 10, 2023
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Present at the Baird 2023 Global Healthcare Conference
September 06, 2023
From
Fortrea Holdings Inc
Via
GlobeNewswire
Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Fortrea Holdings Inc
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.